Neurobiology of depression

Major depressive disorders have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways hold promise as new therapeutics for depression. With the collaboration of the most prestigi...

Full description

Saved in:
Bibliographic Details
Other Authors: Lo´pez-Munoz, Francisco (Editor), A´lamo Gonzalez, Cecilio (Editor)
Format: Book
Language:English
Published: Boca Raton, Florida Taylor & Francis 2012
Series:Frontiers in neuroscience (Boca Raton, Fla.)
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-461842
005 202253091410
008 230213t20122012FLU a #001 deng D
020 # # |a 9781439838495  |q hardback 
020 # # |a 1439838496  |q hardback 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a WM 171.5 
090 0 0 |a WM171.5  |b N4944 2012 
245 0 0 |a Neurobiology of depression  |c edited by Francisco Lopez-Munoz and Cecilio Alamo 
264 # 1 |a Boca Raton, Florida  |b Taylor & Francis  |c 2012 
264 # 4 |c ©2012 
300 # # |a xxx, 492 pages  |b illustrations  |c 27 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
490 1 # |a Frontiers in neuroscience 
504 # # |a Includes bibliographical references and index 
520 # # |a Major depressive disorders have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways hold promise as new therapeutics for depression. With the collaboration of the most prestigious international specialists in biochemistry, molecular biology, genomics, psychiatry, psychology, and pharmacology, Neurobiology of Depression discusses the nature of the central nervous system circuits responsible for the modifications of neuronal functioning that lead to depression. The book begins by discussing animal, neurophysiological, and neuropsychological models of depression as well as neural foundations. It explores genetic factors that contribute to depression and describes the effect of monoaminergic systems in the central nervous system. Next, the book profiles the rise of psychopharmacology in the treatment of depression and the research into serotonin and monoamine reuptake inhibitors. It examines the role of the glutamatergic, endocannabinoid, and opioid systems in the pathophysiology of mood disorders, as well as the effect of biological rhythms on the human body. Later chapters review the role of CRF-related ligands, CRF receptors, HPA axis activity, and glucocorticoid receptors in the regulation of the stress response and depression. They also describe cytokine modulation of molecular mechanisms. They examine the role of neuropeptide Y, nitric oxide, beta-arrestins, BDNF, and phosphodiesterases, and discuss the use of tachykinin antagonists in treatment. Finally, they analyze the neurobiological basis for the development of new antidepressant agents. Exploring myriad aspects of a disease that plagues a large percentage of the population worldwide, this volume captures the state of the science of this debilitating disorder, facilitating further research and discovery 
650 1 2 |a Depressive Disorder  |x physiopathology 
700 1 # |a Lo´pez-Munoz, Francisco  |e editor 
700 1 # |a A´lamo Gonzalez, Cecilio  |e editor 
830 0 # |a Frontiers in neuroscience (Boca Raton, Fla.) 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=461842 
964 # # |c BOK  |d MD